Related Experiment Videos
Pathogenesis of colorectal cancer
1Department of Internal Medicine, University of Modena, Italy. deleon@unimo.it
Summary
Colorectal cancer develops through genetic changes, involving mutations in oncogenes, tumor suppressor, and mutator genes. Understanding these distinct molecular pathways is key for targeted prevention and treatment of intestinal tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) development is a multi-step process involving genetic alterations.
- Key phases include initiation (DNA mutations), promotion, and progression of neoplastic cell growth.
- Alterations in oncogenes, tumor suppressor genes, and mutator genes are crucial in CRC tumorigenesis.
Purpose of the Study:
- To explore the molecular pathways underlying colorectal cancer development.
- To understand the biological diversity of colorectal tumors.
- To identify potential targets for novel prevention and cure strategies.
Main Methods:
- Review of existing evidence on genetic alterations in colorectal cancer.
- Identification and categorization of distinct molecular pathways leading to CRC.
- Analysis of the relationship between molecular pathways and tumor biology.
Main Results:
- Colorectal cancer arises from a series of genetic changes leading to loss of cell growth control.
- Several distinct molecular pathways contribute to CRC, including the "Loss of heterozygosity pathway" and the "mutator genes/microsatellite instability pathway".
- Pathways identified include those for sporadic CRC, familial adenomatous polyposis, hereditary non-polyposis CRC, inflammatory bowel disease-associated CRC, and familial CRC.
Conclusions:
- Multiple molecular pathways contribute to the development of colorectal cancer.
- Tumors arising from different pathways exhibit distinct biological characteristics.
- Recognizing these diverse pathways offers opportunities for tailored preventive and therapeutic approaches.